- Home
- JDZG vs PMN Comparison
JDZG vs PMN Comparison
Compare JDZG & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JDZG
- PMN
- Stock Information
- Founded
- JDZG 2020
- PMN 2004
- Country
- JDZG China
- PMN Canada
- Employees
- JDZG N/A
- PMN N/A
- Industry
- JDZG Other Consumer Services
- PMN Pharmaceuticals and Biotechnology
- Sector
- JDZG Real Estate
- PMN Health Care
- Exchange
- JDZG Nasdaq
- PMN Nasdaq
- Market Cap
- JDZG 29.3M
- PMN 32.3M
- IPO Year
- JDZG 2024
- PMN N/A
- Fundamental
- Price
- JDZG $0.62
- PMN $1.03
- Analyst Decision
- JDZG
- PMN
- Analyst Count
- JDZG 0
- PMN 0
- Target Price
- JDZG N/A
- PMN N/A
- AVG Volume (30 Days)
- JDZG 248.7K
- PMN 88.0K
- Earning Date
- JDZG 12-03-2024
- PMN 12-03-2024
- Dividend Yield
- JDZG N/A
- PMN N/A
- EPS Growth
- JDZG N/A
- PMN N/A
- EPS
- JDZG 0.06
- PMN N/A
- Revenue
- JDZG $2,195,958.00
- PMN N/A
- Revenue This Year
- JDZG N/A
- PMN N/A
- Revenue Next Year
- JDZG N/A
- PMN N/A
- P/E Ratio
- JDZG $11.46
- PMN N/A
- Revenue Growth
- JDZG 52.08
- PMN N/A
- 52 Week Low
- JDZG $0.45
- PMN $0.91
- 52 Week High
- JDZG $15.08
- PMN $3.10
- Technical
- Relative Strength Index (RSI)
- JDZG N/A
- PMN 49.37
- Support Level
- JDZG N/A
- PMN $0.91
- Resistance Level
- JDZG N/A
- PMN $1.08
- Average True Range (ATR)
- JDZG 0.00
- PMN 0.07
- MACD
- JDZG 0.00
- PMN 0.00
- Stochastic Oscillator
- JDZG 0.00
- PMN 62.89
About JDZG JIADE LIMITED Common stock
Jiade Ltd Ltd is engaged in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platforms and auxiliary solutions. The Group offers pre-enrollment guidance on school/selection and application development, training for entrance exams, and assistance in the application process. The Group also offers offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance in the People's Republic of China.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.